Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II randomized double-blind placebo-controlled study of SCTV02 RSV vaccine in healthy adults
CTR20244867Phase 2Active
- Sponsor
- Sinocelltech Group Limited
- Start
- Feb 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SCTV02 in respiratory syncytial virus disease (RSV) (4 arms), sponsored by Sinocelltech Group Limited. Started Feb 2025; status: active.
02
Drugs
SCTV02
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on CTR20244867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244867.